Estimation of vitamin D levels in covid 19 positive patients.

Phase 2

Not yet recruiting

• Conditions: Coronavirus as the cause of diseases classified elsewhere,

• Registration Number: CTRI/2021/02/031230
• Lead Sponsor: Gcs medical hospital

Brief Summary

This study is aimed to explore role of vitamin D levels in covid 19 positive patients and whether its baseline value has any relation to clinical presentation and outcome of the patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-02-15
• Last Update Posted: 2021-10-02

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients who are covid 19 positive either by covid19 rtpcr or rapid antigen or hrct positive.
• Patients who are willing to give consent.
• Above 18 years of age.

Exclusion Criteria

• Patients who are covid 19 negative.
• Patients not willing to give consent.
• Patients below 18 years of age.
• Pregnant and lactating women.
• Patients who have taken vitamin d supplements.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vitamin D levels affecting morbidity and mortality in covid 19 positive patients	1 month

Secondary Outcome Measures

Name	Time	Method
Vitamin d levels in covid 19 positive patients affecting duration of stay in hospital	1 month

Trial Locations

Locations (1)

Gcs hospital; 🇮🇳 Ahmadabad, GUJARAT, India

Gcs hospital

🇮🇳Ahmadabad, GUJARAT, India

Shraddha Tewari

Principal investigator

07966048028

tewari.shraddha23@gmail.com